v3.26.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net income $ 159,920 $ 78,360
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 144,250 174,345
Unrealized foreign currency loss (gain) 13,571 (8,606)
Amortization of debt issuance costs and discount 12,141 18,716
Reclassification of cash flow hedge 8,730 (1,713)
Loss on refinancing 9,270 31,365
Intangible asset impairment charges 975 22,784
Research and development equipment impairment charges 13,832 0
Non-cash property losses 5,035 0
Change in fair value of contingent consideration (6,000) 0
Stock-based compensation 29,723 23,751
Inventory provision 64,981 59,326
Other operating charges and credits, net 4,689 3,575
Changes in assets and liabilities:    
Trade accounts receivable, net (122,423) (110,228)
Inventories (158,346) (66,846)
Prepaid expenses, other current assets and other assets (113,073) (20,173)
Related party receivables 203 (830)
Accounts payable, accrued expenses and other liabilities 17,590 2,744
Related party payables (34,756) 3,107
Net cash provided by operating activities 50,312 209,677
Cash flows from investing activities:    
Acquisition of Kashiv, net of cash and restricted cash acquired (421,047) 0
Purchases of property, plant and equipment (70,659) (48,290)
Acquisition of intangible assets (96,603) (12,514)
Deposits for future acquisition of property, plant and equipment (28,376) (7,384)
Proceeds from sale of property, plant and equipment 0 1,379
Net cash used in investing activities (616,685) (66,809)
Cash flows from financing activities:    
Payments of principal on debt, revolving credit facilities and financing leases (293,172) (2,805,384)
Proceeds from issuance of debt 529,853 2,694,750
Payments of deferred financing and refinancing costs (7,549) (74,973)
Borrowings on revolving credit facilities 280,000 218,000
Proceeds from exercise of stock options 516 1,407
Employee payroll tax withholding on restricted stock unit and performance stock unit vesting (44,696) (21,957)
Tax and other distributions to non-controlling interests (29,571) (38,825)
Proceeds from alliance party 510 5,572
Acquisition of non-controlling interest (400) 0
Net cash provided by (used in) financing activities 435,491 (21,410)
Effect of foreign exchange rate on cash (1,804) (1,471)
Net decrease in cash, cash equivalents, and restricted cash (132,686) 119,987
Cash, cash equivalents, and restricted cash - beginning of period 312,939 118,420
Cash, cash equivalents, and restricted cash - end of period 180,253 238,407
Cash and cash equivalents - end of period 157,399 201,249
Restricted cash - end of period 14,174 34,727
Long-term restricted cash included in other assets - end of period 8,680 2,431
Cash, cash equivalents, and restricted cash - end of period 180,253 238,407
Supplemental disclosure of cash flow information:    
Cash paid for interest 151,671 156,447
Cash paid, net for income taxes 4,558 17,576
Supplemental disclosure of non-cash investing and financing activity:    
Contingent consideration for acquisition - related party 389,000 0
Class A common stock issued in connection with the Kashiv Acquisition 491,610 0
Acquisition of product rights and licenses 602 411
Loan for land purchase - related party $ 0 $ 482